NuGen Medical Devices Inc.
NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.19% | 68.67% | -175.10% | 19.43% | -254.19% |
| Total Depreciation and Amortization | -177.11% | -16.59% | 16.57% | 3.97% | 7.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -233.59% | -89.39% | 466.33% | -47.51% | 159.78% |
| Change in Net Operating Assets | -539.06% | 126.56% | 3.98% | -176.76% | 152.83% |
| Cash from Operations | -11.31% | -2.88% | 7.96% | -49.14% | 10.12% |
| Capital Expenditure | 197.94% | -71.23% | -128.15% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -319.79% | -19,100.00% | 75.00% | 97.91% | -- |
| Cash from Investing | 119.08% | -101.68% | -125.23% | -44.91% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.34% | -17.77% | -1.06% | -48.88% | -4.25% |